ID   MIPTi002-A
AC   CVCL_D4WZ
SY   STCL3
DR   BioSamples; SAMEA114509542
DR   hPSCreg; MIPTi002-A
RX   PubMed=38237426;
CC   From: Moscow Institute of Physics and Technology; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 16783; CDC73; Simple; p.Ile26fs (c.78delC); Zygosity=Heterozygous (PubMed=38237426).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4906; Parathyroid gland carcinoma
DI   ORDO; Orphanet_143; Parathyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   PubMed=38237426; DOI=10.1016/j.scr.2024.103311;
RA   Alsalloum A., Asaad W., Krupinova J., Kegeles E., Sirotkina P.,
RA   Panova A., Mityaeva O., Volchkov P.;
RT   "Generation of induced pluripotent stem cell line (MIPTi002-A) derived
RT   from a patient with a heterozygous type mutation in the CDC73 gene.";
RL   Stem Cell Res. 75:103311-103311(2024).
//